Literature DB >> 27167232

Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review.

Mustafa M Haddad1, Kenneth W Merrell2, Christopher L Hallemeier2, Geoffrey B Johnson1, Taofic Mounajjed3, Kenneth R Olivier2, Jeff L Fidler1, Sudhakar K Venkatesh4.   

Abstract

Stereotactic body radiation therapy (SBRT) is a noninvasive treatment technique for selected patients with primary liver tumors and liver-confined oligometastatic disease. Recently, SBRT has emerged as an alternative treatment option in non-surgical candidates and in whom percutaneous treatment methods are not possible or contraindicated. The experience with SBRT continues to grow. There are currently no imaging guidelines for assessment of tumor response and follow-up schedule following SBRT. SBRT produces characteristic radiation-induced changes in the treated tumor and surrounding liver parenchyma. Knowledge of these changes is essential in the interpretation of follow-up imaging and assessment of treatment response. In this review, we will describe the CT, MRI, and PET imaging findings following SBRT of both the targeted liver tumor and surrounding hepatic parenchyma.

Entities:  

Keywords:  CT; Focal liver reaction; MRI; PET; Stereotactic body radiation therapy; Tumor response

Mesh:

Year:  2016        PMID: 27167232     DOI: 10.1007/s00261-016-0768-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  10 in total

1.  Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.

Authors:  Mishal Mendiratta-Lala; William Masch; Prasad R Shankar; Holly E Hartman; Matthew S Davenport; Matthew J Schipper; Chris Maurino; Kyle C Cuneo; Theodore S Lawrence; Dawn Owen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-09-10       Impact factor: 7.038

2.  Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT.

Authors:  Judit Boda-Heggemann; Anika Jahnke; Mark K H Chan; Leila S Ghaderi Ardekani; Peter Hunold; Jost Philipp Schäfer; Stefan Huttenlocher; Stefan Wurster; Dirk Rades; Guido Hildebrandt; Frank Lohr; Jürgen Dunst; Frederik Wenz; Oliver Blanck
Journal:  Strahlenther Onkol       Date:  2018-02-05       Impact factor: 3.621

3.  Paclitaxel-loaded PLGA microspheres with a novel morphology to facilitate drug delivery and antitumor efficiency.

Authors:  Zongrui Zhang; Xinyu Wang; Binbin Li; Yuanjing Hou; Zhengwei Cai; Jing Yang; Yi Li
Journal:  RSC Adv       Date:  2018-01-16       Impact factor: 4.036

4.  Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.

Authors:  Mishal Mendiratta-Lala; Everett Gu; Dawn Owen; Kyle C Cuneo; Latifa Bazzi; Theodore S Lawrence; Hero K Hussain; Matthew S Davenport
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-08-24       Impact factor: 7.038

5.  Retrospective assessment of a single fiducial marker tracking regimen with robotic stereotactic body radiation therapy for liver tumours.

Authors:  Masao Nakayama; Kazuyuki Uehara; Hideki Nishimura; Shuhei Tamura; Yoshiki Munetomo; Shinji Tsudou; Hiroshi Mayahara; Naritoshi Mukumoto; Moshi Geso; Ryohei Sasaki
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-21

6.  Commentary: Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Zhaonan Li; Dechao Jiao; Xinwei Han
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

7.  Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma.

Authors:  Alessandro Serafini; Valeria Ruggeri; Riccardo Inchingolo; Marco Gatti; Alessia Guarneri; Cesare Maino; Davide Ippolito; Luigi Grazioli; Umberto Ricardi; Riccardo Faletti
Journal:  World J Hepatol       Date:  2022-09-27

Review 8.  Gallbladder cancer revisited: the evolving role of a radiologist.

Authors:  Anupama Ramachandran; Deep Narayan Srivastava; Kumble Seetharama Madhusudhan
Journal:  Br J Radiol       Date:  2020-10-23       Impact factor: 3.039

9.  Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration.

Authors:  Sumin Lee; Hojin Kim; Yunseo Ji; Byungchul Cho; Su Ssan Kim; Jinhong Jung; Jungwon Kwak; Jin-Hong Park; Sang-Wook Lee; Jong Hoon Kim; Sang Min Yoon
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

10.  Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy.

Authors:  Po-Chien Shen; Wen-Yen Huang; Yang-Hong Dai; Cheng-Hsiang Lo; Jen-Fu Yang; Yu-Fu Su; Ying-Fu Wang; Chia-Feng Lu; Chun-Shu Lin
Journal:  Biomedicines       Date:  2022-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.